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Turcot's syndrome is a genetic disease characterized by the concurrence of primary brain tumors and colon cancers and/or multiple colorectal adenomas. We report a Turcot family with no parental consanguinity, in which two aected sisters, with no history of tumors in their parents, died of a brain tumor and of a colorectal tumor, respectively, at a very early age. The proband had a severe microsatellite instability (MIN) phenotype in both tumor and normal colon mucosa, and mutations in the TGFb-RII and APC genes in the colorectal tumor. We identi®ed two germline mutations within the PMS2 gene: a G deletion (1221delG) in exon 11 and a four-base-pair deletion (2361delCTTC) in exon 14, both of which were inherited from the patient's unaected parents. These results represent the ®rst evidence that two germline frameshift mutations in PMS2, an MMR gene which is only rarely involved in HNPCC, are not pathogenic per se, but become so when occurring together in a compound heterozygote. The compound heterozygosity for two mutations in the PMS2 gene has implications for the role of protein PMS2 in the mismatch repair mechanism, as well as for the presymptomatic molecular diagnosis of at-risk family members. Furthermore, our data support and enlarge the notion that high DNA instability in normal tissues might trigger the development of cancer in this syndrome. Oncogene (2000) 19, 1719 ± 1723.
Keywords: Turcot syndrome; PMS2 gene; brain and colorectal tumors; microsatellite instability (MIN) Turcot's syndrome (TS) is characterized by the concurrence of primary brain tumors and multiple adenomas or colorectal cancers that occur at an early age and undergo an even earlier malignant transformation than in familial adenomatous polyposis (FAP) or in hereditary non-polyposis colorectal cancer (HNPCC) (Crail, 1949; Turcot et al., 1959) . The more than 130 cases described to date include such types of brain tumors as glioma, medulloblastoma and astrocytoma, associated with a broad spectrum of colorectal ®ndings, from adenoma to typical adenomatous polyposis (Mastronardi et al., 1991; Itoh et al., 1993; Dupuis and Verellen-Dumoulin, 1995) . It has yet to be established whether the mode of inheritance of typical Turcot's syndrome is dominant or recessive (Lewis et al., 1983; Itoh et al., 1993; Matsui et al., 1998) . Dominantly inherited cases have been associated with germline mutations either within the tumor suppressor adenomatous polyposis coli (APC) gene, which is usually mutated in FAP, or within the mismatch repair (MMR) genes, which are usually mutated in HNPCC (Tops et al., 1992; Mori et al., 1994; Hamilton et al., 1995) . Recently, a Turcot patient with apparently recessive inheritance was found to have a germline mutation within the PMS2 gene that was inherited from his healthy mother (Miyaki et al., 1997) . Although, both FAP and HNPCC are autosomal dominant disorders, the penetrance of mutations in the APC and MMR genes is dierent: close to 100% for FAP, and up to 80% for HNPCC. Although the mode of inheritance of TS will be established as more patients are characterized, it is very important to clarify the penetrance of MMR gene mutations in the pathogenesis of this disease.
Here, we report a Turcot family in which two sisters, with no history of tumors in their parents, were aected by primary brain tumor. One of these (subject III-2 in Figure 1 ) was aected with both brain and colon tumors. The pedigree of this family is reported in Figure 1 . The proband, subject III-2, presented a grade III oligodendroglioma in the right cranioparietal lobe which was removed at the age of 14 years and recurred 3 years later. At the age of 18 years she presented a recto-sigmoid large semipedunculated polyp and a carcinoma in the left colon¯exure. Ultrasound examination of the liver showed a large metastasis (about 16 ± 18 cm in diameter) in the right lobe. She underwent left hemicolectomy and, after an uneventful post-operative period, she died a few months later. Her sister, subject III-1, had a neuroblastoma near the left ventricle of the brain at the age of 13 years and died at the age of 14 years: subjects III-3 (12 years old), III-4 (2 years old), II-1 (48 years old), II-2 (45 years old), II-3 (52 years old), II-4 (54 years old), II-5 (59 years old), and I-2 (84 years old) were healthy at the time of the molecular diagnosis. Subject II-6 died at 63 years of age from a tumor of unknown origin, and subject I-1, with no history of a tumor, died at 84 years of age. Subject II-1 reported being adopted.
To examine whether the disease-causing mutation lies within one of the MMR genes, we analysed the colon carcinoma of the proband (subject III-2) for microsatellite instability at the BAT40, BAT26, D17S250 and D18S69 marker loci. Microsatellite instability, an indicator of the defective mismatch repair system, is characteristic of HNPCC colorectal tumors, of a small fraction of sporadic colon and brain cancers, and of colon carcinomas and adenomas in Turcot patients. The MIN phenotype results from germ line mutations in each of the MMR genes (i.e., MSH2, MLH1, PMS1 and PMS2) and somatic inactivation of the second allele in the tumor tissue (Modrich, 1994; Perucho, 1996; Miyaki et al., 1997; Peltomaki and Vasen, 1997) . We detected alterations at all microsatellite markers analysed. Figure 2a shows the microsatellite instability at markers BAT26 and BAT40 in the colorectal carcinoma, which indicates the involvement of MMR genes. We also analysed the colorectal carcinoma for somatic mutations in the APC and TGF-bRII genes, which are usually involved in tumor development and progression (Marcowitz et al., 1995) . Sequence analysis revealed a heterozygous onebase deletion at the (A) 10 repeated region of the TGFbRII gene, and single strand conformation polymorphism (SSCP), protein truncation test (PTT) and sequence analyses, performed as previously described (Scarano et al., 1997 (Scarano et al., , 1999 , showed a truncating mutation in one allele of the APC gene due to a T insertion at nucleotide 2574 within exon 15 which creates a stop between codons 910 and 911.
We analysed the proband for germline mutations in the coding regions of MLH1 and MSH2, the most frequently mismatch-repair genes involved in the pathogenesis of HNPCC cases with the MIN phenotype (Leach et al., 1993; Papadopoulos et al., 1994; Bronner et al., 1994; Peltomaki and Vasen, 1997) . No variant conformers were observed in either gene by SSCP analysis. Therefore, we analysed by SSCP and sequenced the coding region of the PMS2 gene. As shown in Figure 3 , we detected two truncating mutations: in one allele there was a one-base (G) deletion at nucleotide 1221 (1221delG), codon 407 within exon 11, which creates a stop codon 118 bases downstream, and in the other allele a deletion of 4 bp (CTTC) starting at nucleotide 2361 (2361delCTTC), codon 787 within exon 14, which creates a stop codon a few bases downstream. It is interesting to note that both mutations cause the loss of the MLH1 interaction domain of PMS2, recently located between amino acid residues 675 and 850 (Guerrette et al., 1999) . Our data support the observation that a disruption of the MLH1-PMS2 heterodimer might block the process of the MMR system.
The two mutations were inherited from the patient's mother (subject II-2) and father (subject II-1), respectively. The proband's brothers, subjects III-3 and III-4 were carriers of 2361delCTTC and 1221delG, respectively. The 1221delG mutation was present in the healthy maternal grandmother (subject I-2) and healthy maternal aunts (subjects II-4 and II-5); it was absent from subject II-3. Therefore, transmission of TS caused by PMS2 mutations in this family is recessive since all carriers of one mutation were healthy. Unfortunately, the DNA of the proband's sister who died of neuroblastoma (subject III-1) was not available for molecular diagnosis. Although it cannot be excluded that the neuroblastoma of this subject is a chance association, the occurrence in the same family of healthy carriers and of an aected compound heterozygote subject strongly suggests that she inherited both mutations from her parents.
A high frequency of microsatellite instability (MIN) was found by Miyaki et al. (1997) in normal colon mucosa, normal skin ®broblasts and normal brain tissues of a Turcot patient, in whom only one PMS2 gene mutation has been detected so far, in contrast to HNPCC patients, in which the MIN phenotype was less frequent in normal tissues. Parsons et al. (1995) described some HNPCC patients with germline mutations of PMS2 or MLH1 that had widespread mutations not only in their tumors but also in their non-neoplastic cells.
This result clearly indicated the association of the hypermutability with a profound biochemical defect in the MMR system. To determine the eect in vivo of the Figure 1 Pedigree of the TS family. Filled symbols: clinically aected subjects; open symbols: family members not aected or asymptomatic carriers of one mutation; the arrow indicates the proband. The mutation identi®ed in each subject is reported below the symbol. The proband was a compound heterozygote for PMS2 mutations 2361delCTTC and 1221delG. Subject II-3 is not a carrier of the 1221delG mutation compound heterozygous PMS2 mutations (1221delG and 2361delCTTC) on the mismatch repair system, we compared the BAT40, BAT26 and D18S69 microsatellite markers in individual cells of normal colon mucosa of the proband with those of the normal colon mucosa of an HNPCC patient bearing a germline mutation in the MLH1 gene and showing a mutator phenotype in the colon carcinoma tissue (Panariello et al., 1998) . At the BAT40 marker, microsatellite instability was higher in the normal mucosa of the Turcot patient versus the normal mucosa of the HNPCC patient (Figure 2b ). Microsatellite instability was low at the BAT26 and D18S69 markers (data not shown). The microsatellite alteration in the normal mucosa was not caused by tumor cell contamination, because the normal mucosa was obtained from a region remote from the carcinoma. High DNA instability in normal tissues has been reported in knock-out mice homozygous for PMS2 gene mutations; mutation frequency was 100-fold higher in all tissues examined with respect to both wild-type and heterozygous mice (Narayanan et al., 1997) . Furthermore, the absence of increased somatic mutations in mice heterozygous for the PMS2 disruption prompted the suggestion that a single functional allele provides near-normal repair activity and that PMS2-related genetic instability may, therefore, be recessive (Narayanan et al., 1997). Our Turcot patient, compound heterozygous for 1221delG and 2361del CTTC PMS2 mutations and with the MIN phenotype in both normal and tumor tissue, seems to have the same phenotypic expression as the mice nullizygote for PMS2.
There are several reports of a mutated PMS2 gene in Turcot and HNPCC kindreds. In their Turcot patient, in whom only one PMS2 gene mutation has been detected, Miyaki and colleagues hypothesized that the clinical manifestations and the MIN phenotype in normal colon mucosa might be caused by the concurrence of a second mutation either within PMS2 or other MMR genes (Miyaki et al., 1997) . In the Turcot family (described by Hamilton et al. (1995) and Nicolaides et al. (1998) ) in which the father and his two children were found to carry the PMS2-134 mutation in one allele, both children were clinically aected and had the MIN phenotype in their normal tissues, while the father was healthy at the age of 35 years and no MIN phenotype was found in his normal tissues. In the father, the mutant allele was expressed at lower levels than the wild type allele, while in the children both alleles were expressed at approximately equal levels. Although the dierential expression of the PMS2-134 allele in this kindred has yet to be clari®ed, it has been suggested that this mutation might exert a dominant negative eect, resulting in the biochemical and genetic manifestation of MMR de®ciency only when it is present at a sucient concentration. In the HNPCC patient heterozygous at the PMS2 locus, described by Nicolaides et al. (1994) the colorectal tumor and the disruption of mismatch repair activity in neoplastic tissues was caused by somatic inactivation of the second PMS2 allele which occurred in neoplastic but not in normal tissues.
In the family described herein only the subject who was compound heterozygous for PMS2 mutations developed brain and colorectal tumors at a very early Figure 2 (a) Microsatellite instability analysis at the BAT 26 and BAT40 loci in the proband's normal mucosa and colorectal carcinoma. The microsatellite markers BAT 26 and BAT 40 were ampli®ed from normal and tumor colorectal mucosa DNA, using the primers described by Dietmaier et al. (1997) ; 0.5 ± 1 mg of genomic DNA was ampli®ed with 50 pmol of each primer, 200 mM each of dNTP, 2.5 mM MgCl 2 and 2.5 units of Taq polymerase enzyme with the reaction buer supplied with the kit, in a ®nal volume of 50 ml. Fifteen microliters of ampli®ed DNA and 10 ml of denaturing loading buer were denatured at 958C and electrophoresed on a 6 ± 8% polyacrylamide denaturing gel in 1X TBE (tris-borate-EDTA) buer, at 50 ± 40 mAmp, for about 2 h. Polymerase chain reaction products were visualized by the silver staining method (Budowle et al., 1991) . (b) Microsatellite instability analysis of diluted DNA from normal colorectal mucosa of the Turcot proband and of an HNPCC patient. Genomic diluted DNA was ampli®ed as follows: 3 ± 30 pg of genomic DNA were ampli®ed with 20 pmol of each primer, 200 mM each of dNTP. MgCl 2 2.5 mM, [a 32 P]-ATP and 2.5 units of Taq polymerase enzyme with the reaction buer supplied with the kit, in a ®nal volume of 20 ml . The reaction was performed in a 9600 Perkin Elmer PCR, using the primers described by Dietmaier et al. (1997) . Ten microliters of the ampli®ed DNA and 5 ml of denaturing loading buer were denatured at 958C and electrophoresed on a 6% polyacrylamide denaturing gel in 16 TBE (tris-borate-EDTA) buer, at 25 mAmp, for about 2 h age, thus indicating that TS caused by PMS2 gene mutations has a recessive mode of transmission.
Furthermore, since carriers of the 1221delG or of the 2361delCTTC PMS2 mutations are clinically unaffected, our data suggest a lower penetrance of PMS2 mutations for colorectal tumor development compared to mutations in the MLH1 and MSH2 genes. Accordingly, PMS2 mutations account for very few HNPCC cases: this may indicate that carriers of one mutation do not manifest the disease. In addition, there are no reports of HNPCC patients compound heterozygous for MLH1 or MSH2 mutations, which suggests compound heterozygosity is lethal. Our results have relevant implications in the genetic testing of relatives at-risk and in the management of young patients and asymptomatic subjects. Additional data are necessary to reach a clearer understanding of the PMS2 mechanism of action in the MMR system, and of the role and the penetrance of PMS2 mutations in the pathogenesis of HNPCC and TS.
